| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |